Despite decades of prohibition, psychedelic policy reform has taken off over the past five years. In the United States, at least 28 municipalities have passed local decriminalization (i.e., deprioritization of law enforcement) measures, two states have adopted regulated access models for psilocybin, at least initially, and a sprinkling of states have begun to consider decriminalization for small amounts of certain psychedelics or have enacted reduced penalty statutes applicable to limited, personal use. In 2023 alone, eight localities passed decriminalization initiatives and at least a dozen states introduced psychedelics-focused legislation. Several states have also adopted laws requiring the establishment of working groups to study the potential medical uses of psychedelics and/or have designated funds for academic institutions and other organizations to engage in psychedelic research. For example, Arizona, Minnesota, Nevada, and Washington all passed legislation establishing committees to study psychedelics further in 2023. In other states, proposed legislation continues to face resistance and has been unsuccessful.